SyntheticMR AB has appointed Staffan Persson as Chairman of the Board prior to the planned IPO and spin-off from Accelerator during the fall of 2013.
Staffan Persson has extensive experience of listed companies and is, apart from Chairman of the Board of Accelerator Nordic AB, also Chairman of DIBS Payment Services AB as well as Board Member of The Lexington Company AB, Cinnober Financial Technology AB, as well as several other public and private companies. Through the wholly-owned company Nortal Investments AB, and through his family, Staffan Persson is the largest shareholder of Accelerator with circa 33 percent of voting rights and capital and also owns circa 13 percent of voting rights and capital of SyntheticMR.
”SyntheticMR is focusing on establishing partnerships for an international launch of the software SyMRI and has potential for a very positive value growth”, says Staffan Persson.
Read the full press release from Accelerator in Swedish here.
Read the full press release from Accelerator in English here.
After having evaluated SyntheticMR’s software in connection with follow-up of MS patients, Mattias Vågberg, MD, PhD student, and Anders Svenningsson, MD, Associate Professor, Department of Neurology, Norrlands University Hospital, wrote in BestPractice:
“In our opinion, the presented results show that SyMap can measure brain atrophy in a reliable manner. This makes it possible to bring clinically highly interesting data, which previously only has been available for research purposes, into the clinic.”
“The SyMap method provides an opportunity to actually start putting precise figures on what we in the clinic so far have had to make rough estimates of.”
Read the full article in BestPractice, No. 1, February 2013, here (in Swedish): Ny svensk metod för kvantifiering av hjärnstrukturer.
The medical imaging company SyntheticMR AB, a subsidiary of Accelerator Nordic AB, has, through their partner Sectra, received another order for their magnetic resonance imaging (MRI) software from Västerbotten County in Sweden.
The software, SyMRITM, which is integrated in the hospital’s radiology IT solutions from Sectra, was taken into clinical use at Umeå University Hospital in Västerbotten in 2011 to monitor the treatment efficacy of multiple sclerosis (MS). It is now taken into clinical practice at two more hospitals in the region, Skellefteå and Lycksele.
”In Umeå we use SyMRI for the majority of our neuro exams. Now we want to expand to include more of our MS-patients across the entire region. The data that we collect with SyMRI on MS-patients goes to the national Swedish MS-register in order to add to our knowledge about the development of MS”, says Dr Richard Birgander, Neuroradiologist at Umeå University Hospital.
Torsdagen den 8 november var det avslutningsceremoni för årets upplaga av internationaliseringsprogrammet Go Global Medtech som arrangeras av affärsacceleratorn STING (Stockholm Innovation & Growth) i Kista Science Tower, Stockholm. Juryn, som bestod av erfarna personer från medtechindustrin, utsåg Linköpings-företaget SyntheticMR till årets vinnare av Bästa internationaliseringsplan.
Länk till pressrelease
SyntheticMR ABs nyemission övertecknades med 78 procent
Accelerators dotterbolag SyntheticMR ABs företrädesemission, vars teckningsperiod löpte från 24 september – 8 oktober 2012, övertecknades med 78 procent. Företrädesemissionen tillför SyntheticMR cirka 6,5 miljoner kronor före emissionskostnader.
Länk till pressrelease på svenska
Vi fanns i Sectras monter 11-13 september. Missade du oss? Vi kommer även att finnas tillgängliga i Sectras monter under RSNA
Aktieägarna i Synthetic MR AB, kallas härmed till en extra bolagsstämma onsdagen den 12 september 2012 kl. 13.00 i Accelerator Nordic AB:s lokaler på Grev Turegatan 11 C, 3 tr i Stockholm.
SyntheticMR AB, a subsidiary of Accelerator Nordic AB, has signed an evaluation agreement with a leading MRI system supplier regarding evaluation of its software SyMRI at selected clinics. With the evaluation, the MRI supplier wants to assess the opportunity to sell SyMRI as an add-on option together with the MRI supplier’s MRI systems.
As SyntheticMR has communicated earlier, the company is currently in discussions with leading MRI system suppliers regarding joint commercialization of SyMRI, SyntheticMR’s MRI software for improved efficiency and better decision support. After a positive response from an initial internal appraisal, one of the leading MRI suppliers in question has now signed an agreement regarding a number of evaluation licenses of SyMRI in order to further assess the software’s capabilities at selected customer sites.
From now on you find our new office in the middle of Linköpings city, at St Larsgatan 30.